top of page

Search Results

158 items found for "allosteric modulation"

  • Ep 152 with Dr Arthur Christopoulos

    GPCR Podcast << Back to podcast list A Brief History of allosteric modulation with Dr. involving autoantibodies and allosteric modulators. model for allosteric modulation, emphasizing the balance between mechanism and empiricism. interactions, specifically allosteric modulation. and allosteric modulation in the context of disease and therapeutic approaches.

  • Ep 83 with Dr. Jean-Philippe Pin

    Since then, he has been studying the allosteric modulation and activation mechanism of this family of surface receptors by intracellular proteins; the regulation of GPCRs by both negative and positive allosteric modulators, and the asymmetric functioning of GPCR dimers.

  • 241205

    < Back 241205 Did you know allosteric modulators can change the GPCR G protein subtype selectivity?

  • 241022

    < Back 241022 Did you know allosteric modulators can change the GPCR G protein subtype selectivity?

  • 241210

    < Back 241210 Did you know allosteric modulators can change the GPCR G protein subtype selectivity?

  • 241015

    < Back 241015 Did you know allosteric modulators can change the GPCR G protein subtype selectivity?

  • 241203

    < Back 241203 Did you know allosteric modulators can change the GPCR G protein subtype selectivity?

  • 241029

    < Back 241029 Did you know allosteric modulators can change the GPCR G protein subtype selectivity?

  • 241204

    < Back 241204 Did you know allosteric modulators can change the GPCR G protein subtype selectivity?

  • 241024

    < Back 241024 Did you know allosteric modulators can change the GPCR G protein subtype selectivity?

  • 241022

    < Back 241022 Did you know allosteric modulators can change the GPCR G protein subtype selectivity?

  • 241211

    < Back 241211 Did you know allosteric modulators can change the GPCR G protein subtype selectivity?

  • 241031

    < Back 241031 Did you know allosteric modulators can change the GPCR G protein subtype selectivity?

  • 241212

    < Back 241212 Did you know allosteric modulators can change the GPCR G protein subtype selectivity?

  • Flash News / DrGPCR

    Dec 12, 2024 Did you know allosteric modulators can change the GPCR G protein subtype selectivity? delivered to your inbox. ➡ https:// www.ecosystem.drgpcr.com/gpcr-binders-drugs-and-more/design-of-allosteric-modulators-that-change-gpcr-g-protein-subtype-selectivity 🌟 Researchers have developed reversibly photoswitchable allosteric modulators for Class A GPCRs! modulation with light control, paving the way for new therapeutic strategies targeting muscarinic receptors modulators that bind to the intracellular allosteric binding site to better fine-tune the GPCRs’ activity

  • Ep 113 with Dr. Prasenjit Saha

    More recently, I have shifted my focus to identifying allosteric modulators of host G-protein-coupled However, the pursuit of allosteric modulators has gained attention as they have the potential to fine-tune

  • Advanced data analysis for GPCR pharmacology | Dr. GPCR Ecosystem

    Modules: Module 1 - Concentration-response analysis: Become a CRC super-user. Module 2 - Quantifying agonist pharmacology and biased agonism. Module 3 - Antagonist pharmacology and binding assay analysis. Module 4 - New dimensions of activity: Allosteric modulators and kinetics. He completed his Ph.D. in biochemistry, studying allosteric modulation of dopamine receptors, from the

  • A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer’s Mice

    Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer’s Mice

  • Ep 120 with Brendan Wilkins

    In his Honours year, Brendan explored small molecule allosteric modulators of the β2-adrenoceptor under

  • Ep 39 with Dr. Kathryn E Livingston

    John Traynor , Kathryn worked to develop and understand first-in-class allosteric modulators of opioid

  • Applying Pharmacology to Drug Discovery | Dr. GPCR Ecosystem

    Terry Kenakin On Demand 4 modules - 4 hours total Get Started Premium Members benefits: - Subscribe and Techniques will be described to quantify drug activity in terms of affinity, efficacy, and allosteric Modules: Week 1 - Fundamentals of Pharmacology Week 2 - Characterizing Agonists Week 3 - Characterizing Antagonists Week 4 - Characterizing Allosteric Modulators Good to know Registrations start on December My interests are in receptor theory, pharmacology applied to drug discovery and allosteric protein function

  • Principles of Pharmacology in Drug Discovery I | Dr. GPCR Ecosystem

    The course will focus on the methods used to quantify GPCR ligand activity (agonists, antagonists, modulators Modules: Lecture 1: GPCR Project Initiation and Design for Discovery of New Molecules. Lecture 4: Allosteric Modulators: NAMs, PAMs, Special Properties, Methods to quantify the allosteric My interests are in receptor theory, pharmacology applied to drug discovery and allosteric protein function

  • Ep 37 with Dr. Samuel Hoare

    Samuel Hoare Sam completed his Ph.D. in biochemistry, studying allosteric modulation of dopamine receptors

  • Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5

    contrast, none of the peptides generated a signal on CCR5, but a CCL3-derived tetrapeptide was a positive modulator chemokine N-termini can be mimicked to produce small CCR1-selective agonists, as well as CCR5-selective modulators Ida Aaberg Lillethorup , Jon Våbenø , Katrine Qvortrup , Paul Proost , Mette M Rosenkilde Tags GPCR , allosteric modulation , chemokine , chemokine truncation , pharmacology Source Contribute to the GPCR News Coming

  • Ep 114 with Dr. Robert F. Bruns

    Bruns Fred Bruns discovered the first positive allosteric modulator (PAM) of a GPCR in the late 1980s

  • Ep 82 with Dr. Lauren M. Slosky

    Slosky characterized a new class of β-arrestin biased allosteric modulators (BAMs) for the neurotensin Critically, these ligands reduce addiction-associated behaviors in animal models without the side effects Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor neuroscience approaches, the Slosky Lab is now working to understand how the principles of receptor allosterism

  • Ep 71 with Dr. Jean Martin Beaulieu

    The Beaulieu group is presently investigating how cell surface express proteins can act as allosteric modulators of D2R signaling and explores the potential usefulness of beta-arrestins for the development Translational validation is important to validate findings obtained from experimental models research

  • GPR176 promotes fibroblast-to-myofibroblast transition in organ fibrosis progression

    Similar to the lung fibrosis model, increased Gpr176 expression was also observed in other organs affected Developing a GPR176 inverse agonist or allosteric modulator is a promising therapeutic approach for fibrosis

bottom of page